Nonpeptide endothelin antagonists in clinical development

被引:22
|
作者
Wu, CD [1 ]
Decker, ER [1 ]
Holland, GW [1 ]
Brown, PM [1 ]
Stavros, FD [1 ]
Brock, TA [1 ]
Dixon, RAF [1 ]
机构
[1] Texas Biotechnol Corp, Houston, TX 77030 USA
来源
DRUGS OF TODAY | 2001年 / 37卷 / 07期
关键词
D O I
10.1358/dot.2001.37.7.844187
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:441 / 453
页数:13
相关论文
共 50 条
  • [1] Design and discovery of nonpeptide endothelin antagonists
    Doherty, AM
    DRUG DISCOVERY TODAY, 1996, 1 (02) : 60 - 70
  • [2] DISCOVERY AND DEVELOPMENT OF A NEW SERIES OF ET(A) SELECTIVE NONPEPTIDE ENDOTHELIN ANTAGONISTS
    PATT, WC
    PLUMMER, M
    EDMUNDS, JJ
    BERRYMAN, K
    SHAHRIPOUR, A
    LEE, C
    REISDORPH, BR
    TAYLOR, DG
    WALKER, DM
    WELCH, KM
    SCHROEDER, RL
    OLSZEWSKI, BJ
    HALEEN, S
    DAVIS, LS
    KEISER, JA
    REYNOLDS, EE
    FLYNN, MA
    CHANG, T
    HALLAK, HO
    STEWART, BS
    DOHERTY, AM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 144 - MEDI
  • [3] Clinical development of endothelin receptor antagonists
    Douglas, SA
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (11) : 408 - 412
  • [4] Classification of endothelin antagonists in clinical receptors and development
    Davenport, AP
    Battistini, B
    CLINICAL SCIENCE, 2002, 103 : 1S - 3S
  • [5] The discovery of nonpeptide endothelin receptor antagonists. Progression towards bosentan
    Neidhart, W
    Bren, V
    Bur, D
    Burri, K
    Clozel, M
    Hirth, G
    Muller, M
    Wessel, HP
    Ramuz, H
    CHIMIA, 1996, 50 (11) : 519 - 524
  • [6] Nonpeptide endothelin receptor antagonists .9. Characterization of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists
    Hay, DWP
    Luttmann, MA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 280 (02): : 959 - 965
  • [7] Effects of nonpeptide endothelin receptor antagonists in rats with reduced renal mass
    Clozel, M
    Qiu, CB
    Osterwalder, R
    Roeckel, A
    Bruneval, P
    Heudes, D
    Clozel, JP
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 33 (04) : 611 - 618
  • [8] 1,3-DIARYL-2-CARBOXYINDOLES AS POTENT NONPEPTIDE ENDOTHELIN ANTAGONISTS
    BUNKER, AM
    EDMUNDS, J
    BERRYMAN, K
    HALEEN, S
    FLYNN, MA
    WALKER, DM
    WE
    WELCH, KM
    REYNOLDS, EE
    DOHERTY, AM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 37 - MEDI
  • [9] Nonpeptide endothelin receptor antagonists .7. Binding characteristics of [H-3]SB209670, a novel nonpeptide antagonist of endothelin receptors
    Nambi, P
    Pullen, M
    Wu, HL
    Lee, D
    Saunders, D
    Heys, R
    Aiyar, N
    Leber, J
    Elliott, J
    Brooks, D
    Ohlstein, E
    Ruffolo, R
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 277 (03): : 1567 - 1571
  • [10] NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONISTS .1. EFFECTS ON BINDING AND SIGNAL-TRANSDUCTION ON HUMAN ENDOTHELIN(A) AND ENDOTHELIN(B) RECEPTORS
    NAMBI, P
    ELSHOURBAGY, N
    WU, HL
    PULLEN, M
    OHLSTEIN, EH
    BROOKS, DP
    LAGO, MA
    ELLIOTT, JD
    GLEASON, JG
    RUFFOLO, RR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (02): : 755 - 761